亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Diffusively Permeable Monolithic Biomaterial with Embedded Mircofluidic Channels

详细技术说明
This technology improves wound healing by use of biomaterial embedded with microfluidic networks to allow for active management of the chemistry within the biological matter.
*Abstract

Each year, more than seven million Americans suffer severe acute or chronic cutaneous wounds, many of which cannot be effectively treated with available wound healing methods. An important improvement to the wound healing process would be the ability to deliver and extract reagents on the micrometer scale over the macroscopic dimensions of a typical wound. This type of wound healing would require that a micrometer-scale vascular network be manufactured directly into a porous, biocompatible material.

 

We present a new technology that accomplishes the above-described improvement to wound healing. Cornell’s Vascular Biomaterial (VB) has been embedded with microfluidic networks to allow for active management of the chemistry within the biological matter. The networks can act as an artificial vascular system for synthetic materials, and the VB has potential to act as a scaffold for the more efficient healing of chronic wounds.

 

Potential Applications

Micrometer-scale control of mass-transfer in biomaterials has the potential to impact work in many fields, including:

  • Wound healing
  • Tissue culture
  • Tissue engineering
  • Drug delivery
  • Biological microfabrication

 

Advantages

Vascular Biomaterials offer unprecedented control of the chemical character of the interfaces between synthetic and biological systems. This ability to create artificial tissues that can be integrated into biological tissues addresses two important challenges in the field of wound healing:

1) Clinical treatment of severe cutaneous wounds due to burns or diabetes
2) In vitro modeling of the wound bed and the development of improved epidermal grafts

*Licensing
Carolyn A. Theodorecat42@cornell.edu(607) 254 4514
其他
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备